Plné znění - 2/2008 Sb. m. s.

Xxxxxxxxxxxx zahraničních xxxx xxxxxxx, xx xxx 16. xxxxxxxxx 2007 bylo xxxxxxxxxx xxxxxxxxx XXXXXX, xxxxxxxxxxx Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx¹⁾, xxxxxxxx xxxxxxxxx xxxxxx xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx látek x metod dopingu.

Xxxxxxx I xxxxxxxxx x platnost v xxxxxxx x článkem 34 xxxx. 3 Úmluvy xxx 1. xxxxx 2008 x xxxxx xxxx vstoupila v xxxxxxxx i xxx Xxxxxx republiku. Xxxx xxxxxx Xxxxxxx X x xxxxxxxx xxxxxxxx xxxxxx Xxxxxxx X Xxxxxxxxxxx úmluvy xxxxx xxxxxxx xx xxxxxx xx xxxxx xxx xxx 2007, xxxxxxxxx xxx č. 59/2007 Xx. x. s.

Xxxxxxxx znění Xxxxxxx X a xxxx xxxxxxx do xxxxxxx xxxxxx se xxxxxxxxx xxxxxxxx.

X1. ANABOLICKÉ XXXXX

Xxxxxxxxxx xxxxx jsou xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX STEROIDY (XXX):

x. Exogenní * XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-xxxxxxxxxxxxx (5α-androst-1-en-3,17-dion); xxxxxxxxx (19-xxxxxxxxxxxxxxxx); bolasteron; xxxxxxxx; xxxxxxx (androsta-1,4-dien-3,17-dion); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); desoxymethyltestosteron (17α-xxxxx-5α-xxxxxxx-2-xx-17β-xx); xxxxxxxxxxx; xxxxxxxxxxxxx (19-nor-17α-pregn-4-en-17-ol); xxxxxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); xxxxxxxxx; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; klostebol; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; methandriol; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9-dien-3-on); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9,11-trien-3-on); methyltestosteron; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); xxxxxxxxxx; xxxxxxxxxxxxxx; xxxxxxxxxxxx; xxxxxxxx; oxandrolon; xxxxxxxxxxx; oxymetolon; xxxxxxxxxxx ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); xxxxxxxxx; stanozolol; xxxxxxxxx; 1-xxxxxxxxxxx (17β-hydroxy-5α-androst-1-en-3-on); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); xxxxxxxxx x další xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky.

x. Xxxxxxxxx ** XXX:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), androstendion (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, prasteron (xxxxxxxxxxxxxxxxxxxxx, XXXX), xxxxxxxxxxx x následující metabolity x xxxxxxx:

5α-xxxxxxxxx-3α,17α-xxxx xxxxxxx-5-xx-3β,17α-xxxx

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)

5α-androstan-3β,17α-diol 5-androstendion (xxxxxxx-5-xx-3,17-xxxx)

5α-xxxxxxxxx-3β,17β-xxxx xxx-xxxxxxxxxxxxxxxxxx

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

androst-5-en-3α,17α-diol 19-noretiocholanolon

xxxxxxx-5-xx-3α,17β-xxxx

V xxxxxxxxx, kdy může xxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx steroid xxxxxxxxx, xxxx xx mít xx to, xx Xxxxxx obsahuje tuto Xxxxxxxxx xxxxx x xxxx xxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxx xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxxx x/xxxx xxxx xx xxxxxxxx jiný xxxxxxxxx xxxxx xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx xxxxxx, které se xxxxxxxx xxxxxxxxx x xxxx xxx, xx xxxxxxxxxx xxxxxxxx endogenní xxxxxxxx. Xxxxxx xx xxx xx to, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx x xxxxxxx xxxxxxx, xxxxx Xxxxxxxxx prokáže, že xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx jejích xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx příslušný xxxxx xx Xxxxxx Sportovce xxxxxxxx xxxxxxxxxxxxx xxxx xxxxxxxxxxxx stavem.

Bude xx xxx xx xx, že Vzorek Xxxxxxxxx obsahuje Xxxxxxxxx xxxxx x laboratoř xxxxxxx Pozitivní xxxxxxxxxxx xxxxx xx všech xxxxxxxxx x při xxxxxxxxx koncentraci, xxxxx xxx podle xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx, xx xx Xxxxxxxx xxxxx xxxxxxxxxx xxxxxx. V xxxxxxx xxxxxxx xxxx xxxxx provádět další xxxxxxx.

Xxxx xx xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx xx xxxxxxx xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx x xxxx a xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx exogenní xxxxx Xxxxxxxx xxxxx, xxx xxxxxxxx xxxxxx použití Xxxxxxxx látky, jako xxxx. porovnání x xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx xxxxxxx, xxxx xxxx xxxxxxxxx xxxxxxxxx poměr X/X vyšší než xxxxx (4) ku xxxxx (1) a xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx xxxxx xxxxxxx porovnáním výsledků xxxxxxxxxx testů nebo xxxxxxxxxx xxxxxxxxxx testů.

Xx-xx xxxxxxxxxx takové xxxxx xxxxxxx, xxx xxxxxxxx xxxx laboratoří xxxxxx xxxx xxxxxxxxx x xx xxxx xxxxxxxxx. Xxxxx laboratoř xxxxxxx, xx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. IRMS) xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxxx xxxxx provádět xxxxx xxxxxxx, x xxxx xx xxx xx xx, že Xxxxxx xxxxxxxx Zakázanou xxxxx. Pokud xxxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. IRMS) x nejsou x xxxxxxxxx minimálně 3 xxxxxxxxx xxxxx, bude xxxxxxx longitudinální xxxxxx Xxxxxxxxx xxx, že xxxx xxxxxxxxxx Antidopingovou xxxxxxxxxx x xxxxxxxxxxxxx 3 měsících třikrát xxxxxxxx xxx xxxxxxxxxxx xxxxxxxx. Xxxxxxxx, xxxxx xxxxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxx, xxxx xxxxxx xxxx xxxxxxxxx. Xxxxx xxxxxxxxxxxxxx xxxxxx Sportovce, xxxxxxxx xxxxxxxxxx xxxxx, xxxx fyziologicky xxxxxxxx, xxxx se xxx xxxxxxxxx za Xxxxxxxxx xxxxxxxxxxx nález.

X xxxxxxxx xxxxxxxx individuálních xxxxxxxxx xxxx xxx x moči trvale xxxxxxx xxxxxxxx xxxxxxxxxxx xxxxxx xx velice xxxxxx koncentracích (xx/xx). Xxxxx xxxxxxxxx takový xxxxx xxxxxxxxx x xxxxxxx spolehlivé xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx exogenní původ Xxxxxxxx xxxxx, může xxx xxxxxxxxx xxxxx xxxxxxx xxxxxxxxxx následného xxxxx (xxxxxxxxxx xxxxx).

Xxxxx xxxxxxxxx nahlásila Xxxxxxxxx xxxxxxxxxxx xxxxx 19-xxxxxxxxxxxxxxx, xxxx xx xx považovat xx xxxxxxx x xxxxxxxxxxx xxxxx xxxxxxxxxx xxxxxx Xxxxxxxx xxxxx. X xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx další xxxxxxx.

V xxxxxxx, xx Xxxxxxxxx xxxxxx xxxxxxxxxxxxx xxx dalších xxxxxxxxx, xxxx xx xxx xx xx, xx Xxxxxx Sportovce xxxxxxxx Xxxxxxxxx xxxxx.

2. Ostatní xxxxxxxxxx xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxx xxxxxxxxxx androgenových xxxxxxxxx (XXXX), xxxxxxx, xxxxxxx, xxxxxxxxxx, ale xx x xxxxxxxx xxxxx xx xx.

S2. XXXXXXX X PŘÍBUZNÉ XXXXX

Xxxxxxxxxxx látky x jejich uvolňující xxxxxxx jsou xxxxxxxx:

1. Xxxxxxxxxxxx (XXX);

2. Xxxxxxx xxxxxx (xXX), insulinu podobné xxxxxxx xxxxxxx (např. XXX-1), mechanické růstové xxxxxxx (MGF);

3. Xxxxxxxxxxxxx (xxxx. XX, xXX), xxxxxxxx jen x xxxx;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x xxxxx látky x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxx Xxxxxxxxx xxxxxx xxxxxxxx, xx koncentrace xxxx xxxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxxxxx xxxxxx, bude xx xxx xx xx, že Vzorek xxxxxxxx Zakázanou xxxxx (xxx je xxxxxxx xxxx) x xxxxxxxxx, xxx xxxxxxxxxxx Zakázané xxxxx xxxx jejích xxxxxxxxxx xx xxxxxxxxxx x/xxxx příslušné poměry xx Xxxxxx Xxxxxxxxx xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxxx x xxxx xxx, xx xxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx.

Xxxxx laboratoř xxxxxxxxx, xx užití xxxxxxxxxx xxxxxxxxxx xxxxxx, xx Xxxxxxxx xxxxx xx exogenního xxxxxx, xxxx xx mít xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx x xxxx xxxxxxx Xxxxxxxxx laboratorní xxxxx.

X3. XXXX-2 AGONISTÉ

Všichni xxxx-2 xxxxxxxx xxxxxx xxxxxx D- x X-xxxxxxx jsou zakázáni.

Xxxxxxxx xxxx xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxxx, pro které xx xxx xxxxxxxx xxxxx xxxxxxx zkrácené xxxxxxxxxxxx xxxxxxx.

I xxxx byla xxxxxxx xxxxxxxx xxxxx terapeutické xxxxxxx, bude xxxxx xxxxxxxxxxx (xxxxx xxxx xxxxxxxxxx) xxxxx xxx 1000 xxxxxxxxx x 1 xxxxxxxxx moči xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx nález, pokud Xxxxxxxxx neprokáže, xx xxxxxxxxxx xxxxxxxx xxx xxxxxxxx terapeutickým xxxxxxxx xxxxxxxxxxx v xxxxxxxx.

X4. XXXXXXXXXXX X XXXXXXXXXX XXXXXXX

Xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, zahrnující:

2. Xxxxxxxxxx modulátory xxxxxxxxxxxxx xxxxxxxxx (SERM), xxxxxxxx:

3. Xxxxxxx antiestrogenní látky xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxx včetně xxxxxxxxxx xxxxxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx.

X5. XXXXXXXXX X XXXXXXX XXXXXXXXX XXXXX

Maskovací xxxxx xxxx xxxxxxxx. Xxxxxxxx:

Xxxxxxxxx*, xxxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx xxxx-xxxxxxxxx (xxxx. xxxxxxxxxx, xxxxxxxxxx), plasmaexpandery (xxxx. xxxxxxx, dextran, xxxxxxxxxxxxxxxxx) a xxxxx xxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Diuretika xxxxxxxx:

Xxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, furosemid, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, metolazon, xxxxxxxxxxxxx, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), xxxxxxxxxx x xxxxx xxxxx x podobnou chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky (xxxxx xxxxxxxxxxxx, xxxxx není xxxxxxxx).

* Terapeutická xxxxxxx xxxx platná, xxxxx moč Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx x xxxxxxxx xxxx xxxxxxxxxxx hladinou xxxx Xxxxxxxx xxxxx (xxxxx).

X1. XXXXXXXXX XXXXXXX XXXXXXX

Zakázané xx xxxxxxxxxxx:

X2. XXXXXXXX X XXXXXXXXX XXXXXXXXXX

M3. XXXXXX XXXXXX

Xxxxxxxxxxxxxx xxxxxxx buněk, genů, xxxxxxxx xxxxxxxx, xxxx xxxxxxxxxx exprese xxxx, xxxxx xxxx xxxxxxxxx xxxxxx xxxxxxxxx výkon, xx xxxxxxxx.

X6. STIMULANCIA

Všechna xxxxxxxxxxx (xxxxxx obou xxxxxx xxxxxxxxxx xxxxxxxxx (X- x L-) xxxxxxx) xxxx zakázaná, x xxxxxxxx xxxxxxxx xxxxxxxxx x případě xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxx zahrnutých xx Xxxxxxxxxxxxxx xxxxxxxx xxx xxx 2008.

Xxxxxxxxxxx zahrnují:

Xxxxxxxxx, xxxxxxxxx**, xxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxx, amfetamin, xxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, efedrin****, etamivan, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, fendimetrazin, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, fenproporex, xxxxxxxxx, 4-fenylpiracetam (xxxxxxxx), xxxxxxxxxx, heptaminol, xxxxxxxxxxxx, xxxxx***, klobenzorex, kokain, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, meklofenoxát, xxxxxxxxxxxx (D-), metylefedrin****, xxxxxxxxxxxxxxxxxxxxxx, methylendioxymetamfetamin, xxxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, niketamid, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, parahydroxyamfetamin, xxxxxxx, pentetrazol, x-xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx xxxxxxxxx xxxxxxxx xxxx příklady x xxxxx xxxxxx xxxx xxxxxxxxxx xx xxxxxxxxxxx xxxxx xxxxx, pokud Xxxxxxxxx xxxxxxx, xx xxxx xxxxxxxxx xxxxxxxxxx x běžných xxxxxxxxx xxxxxxxxxxx xxxxxxxx neúmyslné xxxxxxxx antidopingových xxxxxxxx, xxxx je u xxx menší pravděpodobnost, xx xxxx úspěšně xxxxxxxx xxxx xxxxxxxxx xxxxx.

X7. XXXXXXXXX

Xxxxxxxxxxx xxxxxxxxx xxxx zakázaná:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), fentanyl x jeho xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxx, xxxxxxxx, oxymorfon, pentazocin, xxxxxxx.

S8. XXXXXXXXXXX

Kanabinoidy (např. xxxxx, xxxxxxxxx) xxxx xxxxxxxx.

S9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxxxx, xxxxxxxx, xxxxxxxxxx xxxx xxxxxxxxxxxxx xxxxxxxx xxxx xxxxxxxx. Xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxxx.

Xxxx xxxxxxx injekční aplikace (xxxxxxxxxxxx, xx xxxxx xxxxxx, do xxxxx xxxxxx, xxxxxxxxxx, xx xxxx) a xxxxxxxxx xxxxxxxx vyžadují xxxxxxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxxx níže xxxxxxxxx.

Xxxxxxx xxxxxxxxx xxxxxxxx xx xxxxxx kožní (xxxxxx iontoforézy/fonoforézy), xxxx, xxxxx, oční, potíže xxxxx řitního otvoru, xxxxxxxx úst x xxxxx xxxxxx xxxxxxxx x nevyžadují xxxxxx xxxxx xxxxxxxxxxxx xxxxxxx.

X1. XXXXXXX

Xxxxxxx (etanol) xx xxxxxxxx pouze Xxx xxxxxxx x xxxxxxxxxxxxx sportech. Xxxxxxx xx xxxx provádět xxxxxxxx xxxxxxxx a/nebo xxxxxxxx xxxx. Xxxxxxx xxxxxxx pro xxxxxxxx xxxxxxxxxxx xxxxxxxx (xxxxxxxxxxxxx xxxxxxx) je xxx xxxxxx xxxxxxxx xxxxxxx x závorkách.

∙ Xxxxxxxxxxxx xxxxx (FIA) (0.10 x/x)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxx a parašutismus (XXX) (0.20 x/x)

∙ Xxxxxxxxxxx (XXXX, XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxxx (XXXX) xxx pro xxxxxxxxxx xx xxxxxxxx (0.10 g/l)

∙ Motocyklový xxxxx (XXX) (0.10 g/l)

∙ Vodní motorismus (XXX) (0.30 x/x)

∙ Kuželky (IPC) (0.10 x/x)

X2. BETA-BLOKÁTORY

Xxxxx xxxx jinak určeno, xxxx-xxxxxxxxx xxxx xxxxxxxx xxxxx Xxx soutěži x xxxxxxxxxxxxx xxxxxxxx.

∙ Automobilový xxxxx (XXX)

∙ Xxxxxxxx (XXXX)

∙ Boby (XXXX)

∙ Xxxxx (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Xxxxxxxx (XXXX) - "xxxxx xxxx" - jen xxxxxxxxxxx

∙ Kuželky (XXX)

∙ Xxxxxxx xxxxxx x parašutismus (XXX)

∙ Lukostřelba (XXXX, IPC) (zakázané xxxx Xxxx soutěž)

∙ Xxxxxxxx (FIS) - skoky xx xxxxxx x xxxxxxxxxxx xxxxxxxx-xxxxx x X-xxxxx, x xxxxxxxxx X-xxxxx x "xxx xxx"

∙ Moderní xxxxxxx (XXXX) - xxx xxxxxxxxxx xx xxxxxxxx

∙ Xxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx x xxxxxxx xxxxxx (XXXX, XXX "xxxxx")

∙ Xxxxxxx (ISSF, XXX) (xxxxxxxx xxxx Xxxx xxxxxx)

∙ Xxxxx motorismus (UIM)

∙ Xxxxx (XXXX)

Xxxx-xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxx:

Xxxxxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxx, karvedilol, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxxxx, sotalol, xxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx

"Xxxxxxxxxx xxxxx"* xxxx vyjmenovány níže:

∙ Xxxxxxx Beta-2 xxxxxxxx x xxxxxxxx, xxxxx xxxxxxxxxxx (xxxxxxx xxxx glukuronidu) xxx xxxxxxxx xxxxxx xxx 1000 ng/ml xxxx x clenbuterolu (xxxxxxx xx xxxxxxx X 1.2 Ostatní anabolické xxxxx);

∙ Inhibitory xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, haptaminol, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxxxx, x-xxxxxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, selegilin, xxxxxxxxxx, xxxxxxxxxxxxx x xxxxxxx xxxxxxx xxxxxxxxxxx neuvedená xxxxxxxx x xxxxxx X6, xxx xxxxx Xxxxxxxxx xxxxxxx, že xxxxxxx xxxxxxxx xxxxxxx x xxxxxx X6;

∙ Xxxxxxxxxxx;

∙ Xxxxxxx Glukokortikosteroidy;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"X Xxxxxxx xxxxx xxx vyjmenovány xxxxxxxxxx xxxxx, xxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxxxxx jsou xxxxxxxxx xxxxxxxx v xxxxxxx xxxxxxxxx přípravcích, nebo x nichž xx xxxxx xxxxxxxxxxxxxxx, xx xxxxx xxxxxxx zneužity xxxx dopingová xxxxxxx." Xxxxxxxx antidopingového xxxxxxxx xxxxxxxxxx xxxxxxxx látky xxxx xxxxxxxx xxxxxxx xxxxxx xx xxxxxxxxxxx, xx "...Sportovec může xxxxx prokázat, že Xxxxxxx xxxxxxxxxx xxxxx xxxxxx xxxxxxxxx ke xxxxxxx sportovního výkonu...".

Xxxxxx předpis x. 2/2008 Xx. x. x. xxxxx xxxxxxxxx xxxx 31.1.2008.

Xxxxxx xxxxxxx x. 2/2008 Xx. x. x. byl zrušen xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x účinností xx 7.2.2009.

Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx právních předpisů x xxxxxxxx není xxxxxxxxxxxxx, pokud xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx předpisu.